Focus is to discover small molecule lead candidates for multiple oncology indications Darmstadt, Germany, Krakow, Poland, November 2, 2015 / B3C newswire / -- Merck, a leading science and technology company, announced today that its healthcare business has …
Nijmegen/Utrecht, the Netherlands, October 29, 2015 / B3C newswire / -- InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. …
Trastuzumab Development and Transfer for First Indonesian On-Site Production Berlin, Germany, and Bandung, West Java, Indonesia, October 28, 2015 / B3C newswire / -- ProBioGen AG and Bio Farma signed an agreement for the development of a biosimilar …
Berlin, Germany, October 27, 2015 / B3C newswire / -- BioGenes GmbH, a global leader in host cell protein (HCP) assay development, today announced that it has launched a generic HCP assay with improved HCP recovery properties for E.coli cells. The E.coli| …
Uppsala, Sweden, October 26, 2015 / B3C newswire / -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the introduction of Isolera™ Assist, a new intelligent …
LUNARIS™ multiplexing platform is applied in epidemiological studies for AMD Cologne, Germany, October 22, 2015 / B3C newswire / -- AYOXXA Biosystems GmbH, an international biotechnology company, is one of two industrial partners of EYE-RISK, a large …
Copenhagen, Denmark, October 19, 2015 / B3C newswire / -- Nuevolution A/S today announced that it has entered into collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, using Nuevolution’s …
Berlin, Germany, and Uppsala, Sweden, October 15, 2015 / B3C newswire / - BioGenes GmbH, a global leader in host cell protein (HCP) assay development, and Gyros AB, a pioneer in miniaturizing and automating immunoassays at nanoliter-scale, announce a …
New S80 film features consistent cell growth, robustness and high quality Flexsafe® 3D shipping solutions meet stringent ASTM D4169 Standard Practice Pre-designed Solutions (PDS) proven for every process step in biomanufacturing Goettingen, Germany and …
Cancer Vaccine OQR200 Elicits Broad and Strong Immune Response to Her2/neu Vienna, Austria, October 15, 2015 / B3C newswire / -- OncoQR ML, a company developing Adjustable Cancer Immunotherapies, today announced that its breast cancer vaccine candidate …
Company’s second office in the region will strengthen customer relations and help develop new business among emerging and established Japanese companies Tokyo, Japan, and Ravensburg, Germany, October 14, 2015 / B3C newswire / -- Vetter, one of the global …
Munich, Germany and Fountain Valley, CA, United States, October 14, 2015 / B3C newswire / -- Isarna Therapeutics, the leader in transforming growth factor beta (TGF-ß) isoform targeted antisense therapeutics, and Autotelic Inc., a specialist in …
Cancer Antibody With Enhanced ADCC Potency to be Produced Berlin, Germany and Vancouver, Canada, October 14, 2015 / B3C newswire / -- ProBioGen AG, a leading specialist for contract development and manufacturing of complex glycoproteins, and Zymeworks Inc …
Warsaw, Poland, October 13, 2015 / B3C newswire / - On October 13, 2015, OncoArendi Therapeutics Ltd. announced that it selected OATD-01 as its clinical development candidate for the treatment of asthma. Submission of the Company's first …
Ajdovscina, Slovenia, October 13, 2015 / B3C newswire / -- BIA Separations is introducing a second generation CIMac™ r-Protein A Analytical Column. This short bed, high performance monolithic column is primarily intended for fast, efficient, and …
Basel, Switzerland, and Konstanz, Germany, October 6, 2015 / B3C newswire / -- Konstanz based contract research organization Trenzyme GmbH and Basel based Celonic AG today announced the closure of a licence agreement on Celonics CHO-K1 based cell line …
ADCC-enhancement for innovative cancer therapy, produced via ProBioGen’s accelerated CMC development path. Berlin, Germany, and South San Francisco, CA, USA, October 1, 2015 / B3C newswire / -- ProBioGen AG and Tizona Therapeutics, Inc. have signed a …
Horsholm, Denmark, October 1, 2015 / B3C newswire / -- ExpreS2ion Biotechnologies, a private Danish company, ("ExpreS2ion") announced today the execution with Boston Children’s Hospital ("Boston Children’s”), located in Boston, Massachusetts …
First activities resulting from the investment already underway Ravensburg, Germany, September 30, 2015 / B3C newswire / -- Vetter has announced that in keeping with its commitment to providing customers with the manufacture of high quality drug products, …
Researchers Present Data at Breast Cancer Symposium Showing MammaPrint/BluePrint Can Identify Women Who Benefit from Chemotherapy and Targeted Dual Anti-HER2 Drug Treatment Before Surgery Irvine, CA, USA and Amsterdam, the Netherlands, September 30, 2015 / …
